Table 2.

Additional pharmacokinetic properties in those with normal kidney function

OACCmax, ht1/2, hProtein binding, %VD, LBioavailability, %
Warfarin2–64297–991099
Dabigatran1–212–143850–703–7
Apixaban3–412872150
Rivaroxaban2–46–13>905066–100
Edoxaban1–210–145510762
  • OAC, oral anticoagulant; Cmax, peak concentration; VD, volume of distribution.